Development and validation of an intrinsic landmark-based gating protocol applicable for functional and molecular ultrasound imaging

European Radiology

Volumn 22, Issue 8, 2012, Pages 1789-1796

  Grouls, Christoph ^a   Hatting, Max ^b   Tardy, Isabelle ^c   Bzyl, Jessica ^a   Mühlenbruch, Georg ^a   Behrendt, Florian F ^a   Penzkofer, Tobias ^a   Trautwein, Christian ^b   Kuhl, Christiane ^a   Kiessling, Fabian ^a   Palmowski, Moritz ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c Bracco Suisse SA   (Switzerland)

Author keywords

Contrast enhanced; Functional imaging; Gating; Molecular imaging; Ultrasound

Indexed keywords

SONOVUE; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREATHING MECHANICS; CONTRAST ENHANCEMENT; ECHOGRAPHY; GATED IMAGING; GOLD STANDARD; MICROBUBBLE; MOLECULAR IMAGING; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CONTRAST MEDIA; HUMANS; IMAGING, THREE-DIMENSIONAL; LIVER; MICE; MICE, KNOCKOUT; MICROBUBBLES; REPRODUCIBILITY OF RESULTS; RESPIRATION; RESPIRATORY-GATED IMAGING TECHNIQUES; RETROSPECTIVE STUDIES; TIME FACTORS; ULTRASONOGRAPHY; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84864715062     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-012-2429-y     Document Type: Article

References (22)

1. Averkiou M, Lampaskis M, Kyriakopoulou K et al (2010) Quantification of tumor microvascularity with respiratory gated contrast enhanced ultrasound for monitoring therapy. Ultrasound Med Biol 36:68-77
2. Beraza N, Malato Y, Sander LE et al (2009) Hepatocyte-specific NEMO deletion promotes NK/NKT cell-And TRAIL-dependent liver damage. J Exp Med 206:1727-1737
3. Bettermann K, Vucur M, Haybaeck J et al (2010) TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancer. Cancer Cell 17:481-496
4. Blessberger H, Binder T (2010) Non-invasive imaging. Two dimensional speckle tracking echocardiography: basic principles. Heart 96:716-722
5. Bzyl J, Lederle W, Rix A et al (2011) Molecular and functional ultrasound imaging in differently aggressive breast cancer xenografts using two novel ultrasound contrast agents (BR55 and BR38). Eur Radiol 21:1988-1995
6. Garbow JR, Ackerman JJ (2011) Imaging primary lung cancers in mice to study radiation biology: in regard to Kirsch et al. (Int J Radiat Oncol Biol Phys 2010;76:973-977). Int J Radiat Oncol Biol Phys 79:959, author reply 959
7. Hotz HG, Reber HA, Hotz B et al (2003) An orthotopic nude mouse model for evaluating pathophysiology and therapy of pancreatic cancer. Pancreas 26:e89-e98
8. Kang BH, Siegelin MD, Plescia J et al (2010) Preclinical characterization of mitochondria-Targeted small molecule hsp90 inhibitors, gamitrinibs, in advanced prostate cancer. Clin Cancer Res 16:4779-4788
9. Kerbel RS, Cornil I, Theodorescu D (1991) Importance of orthotopic transplantation procedures in assessing the effects of transfected genes on human tumor growth and metastasis. Cancer Metastasis Rev 10:201-215
10. Kiessling F,Gaetjens J, PalmowskiM(2011) Application ofmolecular ultrasound for imaging integrin expression. Theranostics 1:127-134
11. Kiessling F, Huppert J, Palmowski M (2009) Functional and molecular ultrasound imaging: concepts and contrast agents. Curr Med Chem 16:627-642
12. Mule S, Kachenoura N, Lucidarme O et al (2011) An automatic respiratory gating method for the improvement of microcirculation evaluation: application to contrast-enhanced ultrasound studies of focal liver lesions. Phys Med Biol 56:5153-5165
13. Orlacchio A, Bolacchi F, Petrella MC et al (2011) Liver contrast enhanced ultrasound perfusion imaging in the evaluation of chronic hepatitis C fibrosis: preliminary results. Ultrasound Med Biol 37:1-6
14. Palmowski M, Huppert J, Ladewig G et al (2008) Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects. Mol Cancer Ther 7:101-109
15. Palmowski M, Lederle W, Gaetjens J et al (2010) Comparison of conventional time-intensity curves vs. maximum intensity over time for post-processing of dynamic contrast-enhanced ultrasound. Eur J Radiol 75:e149-e153
16. Palmowski M, Peschke P, Huppert J et al (2009) Molecular ultrasound imaging of early vascular response in prostate tumors irradiated with carbon ions. Neoplasia 11:856-863
17. Paprottka PM, Cyran CC, Zengel P et al (2010) Non-invasive contrast enhanced ultrasound for quantitative assessment of tumor microcirculation. Contrast mixed mode examination vs. only contrast enhanced ultrasound examination. Clin Hemorheol Microcirc 46:149-158
18. Pillai R, Marinelli ER, Fan H et al (2010) A phospholipid-PEG2000 conjugate of a vascular endothelial growth factor receptor 2 (VEGFR2)-Targeting heterodimer peptide for contrast-enhanced ultrasound imaging of angiogenesis. Bioconjug Chem 21:556-562
19. Pochon S, Tardy I, Bussat P et al (2010) BR55: a lipopeptide-based VEGFR2-Targeted ultrasound contrast agent for molecular imaging of angiogenesis. Invest Radiol 45:89-95
20. Renault G, Tranquart F, Perlbarg V, Bleuzen A, Herment A, Frouin F (2005) A posteriori respiratory gating in contrast ultrasound for assessment of hepatic perfusion. Phys Med Biol 50:4465-4480
21. Willmann JK, Paulmurugan R, Chen K et al (2008) US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Radiology 246:508-518
22. Willmann JK, van Bruggen N, Dinkelborg LM, Gambhir SS (2008) Molecular imaging in drug development. Nat Rev Drug Discov 7:591-607